Vivanza Biosciences Ltd

Vivanza Biosciences Expands into Packaging & Posts Q3 Results 📊🔄

- Revenue from operations: ₹5,373.18 lakhs (standalone) and ₹5,535.78 lakhs (consolidated) for Q3 (Sept 30, 2025).

- Profit before tax: ₹46.21 lakhs (standalone) and ₹56.29 lakhs (consolidated).

- Basic/diluted EPS: ₹0.12 (standalone) and ₹0.14 (consolidated).

- Proposed expansion into plastic polymer films, bags, and flexible packaging—pending shareholder approval via Postal Ballot (voting: Nov 17–Dec 16, 2025; results by Dec 18).

- New Company Secretary & Compliance Officer appointed: CS Chaitra Arora (effective Nov 11, 2025).

- Scrutinizer for Postal Ballot: Mr. Chintan K. Patel.